Does Affimed NV (AFMD) Stack Up Against Its Peers?

We view hedge fund activity in the stock as unfavorable, but in this case there was only a single hedge fund selling its entire position: LMR Partners. One hedge fund selling its entire position doesn’t always imply a bearish intent. Theoretically a hedge fund may decide to sell a promising position in order to invest the proceeds in a more promising idea. However, we don’t think this is the case in this case because only one of the 800+ hedge funds tracked by Insider Monkey identified as a viable investment and initiated a position in the stock (that fund was D E Shaw).

Let’s also examine hedge fund activity in other stocks similar to Affimed NV (NASDAQ:AFMD). These stocks are CIBER, Inc. (NYSE:CBR), ADMA Biologics Inc (NASDAQ:ADMA), Harvard Bioscience, Inc. (NASDAQ:HBIO), and Xcel Brands Inc (NASDAQ:XELB). All of these stocks’ market caps are closest to AFMD’s market cap.

As you can see these stocks had an average of 5 hedge funds with bullish positions and the average amount invested in these stocks was $18 million. That figure was $20 million in AFMD’s case. CIBER, Inc. (NYSE:CBR) is the most popular stock in this table. On the other hand Xcel Brands Inc (NASDAQ:XELB) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks Affimed NV (NASDAQ:AFMD) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None